Thompson Rahsaan
- SEC CIK
- 0001788524
In the past year, 4 open-market sale filings worth $969.3K and no purchases.
Current role at each company
- ZVRA Zevra Therapeutics, Inc.Chief Legal & Complianceas of Aug 17, 2026
- LYEL Lyell Immunopharma, Inc.Chief Legal Officeras of Feb 28, 2023
- GRTS Gritstone bio, Inc.EVP and General Counselas of Apr 20, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $969.3K
- 4 filings
- Net
- −$969.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Thompson Rahsaan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZVRA Zevra Therapeutics, Inc.
Chief Legal & Compliance5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 (view filing)4:32 PM ET | Aug 14 | 3 days | Thompson RahsaanChief Legal & Compliance | SSale | −42.7K | $11.13 | −$474.8K | −53.2%37.6K after | 10b5-1 |
| Jun 23, 2026 (view filing) | Jun 22 | 1 day | Thompson RahsaanChief Legal & Compliance | SSale | −34.6K | $12.68 | −$438.2K | −30.1%80.2K after | 10b5-1 |
| May 13, 2026 (view filing) | May 11 | 2 days | Thompson RahsaanChief Legal & Compliance | SSale | −1.79K | $11.30 | −$20.3K | −3.6%48.1K after | 10b5-1 |
| Feb 2, 2026 (view filing) | Jan 30 | 3 days | Thompson RahsaanChief Legal & Compliance | SSale | −4.08K | $8.83 | −$36.0K | −7.6%49.9K after | 10b5-1 |
| Jun 30, 2025 (view filing) | Jun 26 | 4 days | Thompson RahsaanChief Legal & Compliance | SSale | −24.0K | $9.21 | −$221.0K | −36.0%42.7K after | 10b5-1 |